Alterations in p53, p21, and MIB-1 Labeling Index in Primary Human Astrocytomas Following Radiation Therapy
Authors:
- 1 September 2005
- journal article
- laboratory investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 74 (2) , 151-154
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.2002
- Regulation of p53 in response to DNA damageOncogene, 1999
- Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progressionNeuro-Oncology, 1999
- Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.1998
- Controlling Epidermal Growth Factor (EGF)-stimulated Ras Activation in Intact Cells by a Cell-permeable Peptide Mimicking Phosphorylated EGF ReceptorJournal of Biological Chemistry, 1996
- Radiation response and survival time in patients with glioblastoma multiformeJournal of Neurosurgery, 1996
- Human gliomas with wild-type p53 express bcl-2.1995
- High levels of p53 protein in UV-irradiated normal human skin.1993
- Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic TumorsJournal of Neuropathology & Experimental Neurology, 1993
- High dose radiation therapy in the treatment of malignant gliomas: Final ReportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1979